GlaxoSmithKline (GSK) Purchased Sierra Oncology For $1.9-Billion
The company ‘GlaxoSmithKline Plc’ has agreed for purchasing the biotech company known as Sierra Oncology for $1.9 billion as the drugmaker of the United Kingdom for the purpose of strengthening its lineup of the medicines for fighting the cancer disease and also preparing to spin off the consumer health unit of the company. The company […]
Continue Reading